Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Nordic guidelines 2021 for diagnosis and
Final published version, 1.75 MB, PDF document
BACKGROUND: The diagnostic work-up and treatment of patients with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) has undergone major advances and new methods are introduced. Furthermore, an update of the WHO classification has resulted in a new nomenclature for GEP-NEN that is implemented in the clinic.
AIM: These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat GEP-NEN patients and aims to be useful in the daily practice for clinicians.
| Original language | English |
|---|---|
| Journal | Acta Oncologica |
| Volume | 60 |
| Issue number | 7 |
| Pages (from-to) | 931-941 |
| Number of pages | 11 |
| ISSN | 1100-1704 |
| DOIs | |
| Publication status | Published - 2021 |
Bibliographical note
Publisher Copyright:
© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
- Diagnosis, neuroendocrine carcinoma, neuroendocrine tumour, treatment
Research areas
Number of downloads are based on statistics from Google Scholar and www.ku.dk
ID: 262914043